Nextage Therapeutics Ltd (TLV:NXTG)
Israel · Delayed Price · Currency is ILS · Price in ILA 36.10
-0.70 (-1.90%)
Oct 13, 2026, 5:24 PM IDT
Nextage Therapeutics Market Cap
Nextage Therapeutics has a market cap or net worth of 29.26 million as of October 13, 2026. It is the 41,806th most valuable company in the world and the 448th biggest in Israel. Its market cap has increased by 11.48% in one year.
Market Cap
29.26M
Enterprise Value
36.39M
Revenue
2.51M
Global Rank
Country Rank
#448 Israel
PE Ratio
n/a
ChartMarket Cap Chart
Since February 29, 2024, Nextage Therapeutics's market cap has increased from 12.50M to 29.26M, an increase of 134.09%. That is a compound annual growth rate of 38.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 29.26M | 23.16% |
| Dec 31, 2024 | 23.76M | 90.07% |
| Feb 29, 2024 | 12.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Danel (Adir Yeoshua) | 2.53B |
| Amal Holdings A.D. | 2.19B |
| Rafa Laboratories | 1.68B |
| Kamada | 1.42B |
| Clal Biotechnology Industries | 37.33M |
| BioLineRx | 35.84M |
| Together Pharma | 34.68M |
| Purple Biotech | 32.42M |